The Parkland Center for Clinical Innovation has appointed Michael Sachs as the newest member of its board of directors. Sachs is an “added” member and will not be replacing anyone on the board.
Currently, Sachs serves as chairman of TLSG Inc., an investment advisory and consulting firm based in Chicago. His experience is entirely healthcare-related, focusing on developing data and information companies. Sachs mostly works with startups and early-stage companies in the healthcare, biomedical, and data science fields.
Sachs will join five other members of PCCI’s board: Dr. Fred Cerise, president and CEO of Parkland Health & Hospital Systems; Dr. Steve Miff, president and CEO of PCCI; Dr. Winfred Parnell, an OBGYN and chair of the board of managers at Parkland; Ted Shaw, president and CEO of Texas Hospital Association; and Bob Smith, a healthcare consultant.
Miff said in a statement: “I am very excited and honored that Michael is joining the PCCI board. He is a top healthcare executive and visionary, and has been a personal mentor and role model for the last 15 years. His passion for transforming healthcare and his insights and guidance will help us expand PCCI’s innovation and impact.”
Sachs earned his bachelor’s and master’s degrees from the University of Missouri, Columbia.